Provided by Tiger Trade Technology Pte. Ltd.

BiomX Inc.

0.1375
-0.0022-1.57%
Post-market: 0.13880.0013+0.95%19:59 EDT
Volume:966.36K
Turnover:133.43K
Market Cap:3.65M
PE:-0.01
High:0.1400
Open:0.1340
Low:0.1340
Close:0.1397
52wk High:12.29
52wk Low:0.1192
Shares:26.56M
Float Shares:11.49M
Volume Ratio:1.31
T/O Rate:8.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.1051
EPS(LYR):-63.8993
ROE:-247.34%
ROA:-42.35%
PB:0.84
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
BiomX Inc.
Exchange:
AMEX
Establishment Date:
2015
Employees:
20
Office Location:
850 New Burton Road,Suite 201,Dover,Delaware,United States
Zip Code:
19904
Phone:
- -
Fax:
- -
Introduction:
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Directors

Name
Position
Michael Oster
Chief Executive Officer and Director
Roy Rousso
Chief Business Officer and Director
Amir Shalom
Director
Guy Arieli
Director
Liat Bidas
Director
Reuven Yeganeh
Director
Ran Shaked
Director

Shareholders

Name
Position
Michael Oster
Chief Executive Officer and Director
David Rokach
Chief Financial Officer and Principal Accounting Officer
Roy Rousso
Chief Business Officer and Director